Novel Derivatives of Quinoxaline-2-carboxylic Acid 1,4-Dioxides as Antimycobacterial Agents: Mechanistic Studies and Therapeutic Potential
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Derivatives of Quinoxaline-2-carboxylic Acid 1,4-Dioxides as Antimycobacterial Agents: Mechanistic Studies and Therapeutic Potential
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 16, Issue 11, Pages 1565
Publisher
MDPI AG
Online
2023-11-06
DOI
10.3390/ph16111565
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quinoxaline 1,4-Dioxides: Advances in Chemistry and Chemotherapeutic Drug Development
- (2023) Galina I. Buravchenko et al. Pharmaceuticals
- Synthesis and Characterization of Novel 2-Acyl-3-trifluoromethylquinoxaline 1,4-Dioxides as Potential Antimicrobial Agents
- (2022) Galina I. Buravchenko et al. Pharmaceuticals
- An ionic gold(III)–zinc(II) pseudo-polymeric compound of [H3O][Au{S2CN(CH2)5}2]3[ZnCl4]2: Synthesis, supramolecular architecture and anti-tuberculosis activity
- (2022) Olga V. Loseva et al. POLYHEDRON
- WHO's Global Tuberculosis Report 2022
- (2022) Sanjeet Bagcchi Lancet Microbe
- Discovery of novel DprE1 inhibitors via computational bioactivity fingerprints and structure-based virtual screening
- (2021) Xue-ping Hu et al. ACTA PHARMACOLOGICA SINICA
- Genetic diversity of candidate loci linked to Mycobacterium tuberculosis resistance to bedaquiline, delamanid and pretomanid
- (2021) Paula J. Gómez-González et al. Scientific Reports
- MmpS5-MmpL5 Transporters Provide Mycobacterium smegmatis Resistance to imidazo[1,2-b][1,2,4,5]tetrazines
- (2020) Dmitry A. Maslov et al. Pathogens
- Identification of Mutations Conferring Tryptanthrin Resistance to Mycobacterium smegmatis
- (2020) Svetlana G. Frolova et al. Antibiotics-Basel
- The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model
- (2019) Yang Liu et al. Nature Communications
- Discovery and Biosynthesis of Atrovimycin, an Antitubercular and Antifungal Cyclodepsipeptide Featuring Vicinal-dihydroxylated Cinnamic Acyl Chain
- (2019) Qing Liu et al. ORGANIC LETTERS
- Pre-clinical evaluation of quinoxaline-derived chalcones in tuberculosis
- (2018) Thaís C. Muradás et al. PLoS One
- Radical Chemistry and Cytotoxicity of Bioreductive 3-Substituted Quinoxaline Di-N-Oxides
- (2016) Robert F. Anderson et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Quinoxaline 1,4-di-N-Oxides: Biological Activities and Mechanisms of Actions
- (2016) Guyue Cheng et al. Frontiers in Pharmacology
- In Silico Studies of Quinoxaline-2-Carboxamide 1,4-di-N-Oxide Derivatives as Antimycobacterial Agents
- (2014) Awwad Radwan et al. MOLECULES
- Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline
- (2014) Koen Andries et al. PLoS One
- VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
- (2012) D. C. Koboldt et al. GENOME RESEARCH
- A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data
- (2011) H. Li BIOINFORMATICS
- Initiation of DNA Strand Cleavage by 1,2,4-Benzotriazine 1,4-Dioxide Antitumor Agents: Mechanistic Insight from Studies of 3-Methyl-1,2,4-benzotriazine 1,4-Dioxide
- (2008) Venkatraman Junnotula et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5–MmpL5 efflux system
- (2008) Anna Milano et al. TUBERCULOSIS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started